NCT06668896View on ClinicalTrials.gov

Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions
Pre Term Birth
Interventions
DRUG

Progesterone

Each arm will administer different amounts of progesterone vaginally (8mg to 100mg) over a 14-15 day time period.

Sponsors
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Daré Bioscience, Inc.

INDUSTRY